Gene · 974
Papers4,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 4,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lymphoma dissemination is a pathological hallmark for malignant progression of B-cell lymphoma. | Front Immunol | 2023 | 38077394 | PubTator, text mining | PubMed |
| Asian variant intravascular large B-cell lymphoma with highly suspected central nervous system involvement: A case report. | World J Clin Cases | 2023 | 38075582 | PubTator, text mining | PubMed |
| Up-regulated SPP1 increases the risk from IPF to lung cancer via activating the pro-tumor macrophages. | Comput Struct Biotechnol J | 2023 | 38074471 | PubTator, text mining | PubMed |
| Developing New Strategies for Relapsed/Refractory Diffuse Large B-Cell Lymphoma. | J Clin Med | 2023 | 38068428 | PubTator, text mining | PubMed |
| Characterization of novel CD19-specific VHHs isolated from a camelid immune library by phage display. | J Transl Med | 2023 | 38066569 | PubTator, text mining | PubMed |
| Single-cell transcriptomics reveals variations in monocytes and Tregs between gout flare and remission. | JCI Insight | 2023 | 38063198 | PubTator, text mining | PubMed |
| Lower myostatin and higher MUC1 levels are associated with better response to mepolizumab and omalizumab in asthma: a protein-protein interaction analyses. | Respir Res | 2023 | 38057814 | PubTator, text mining | PubMed |
| [The value of CD200 in differential diagnosis of classic hairy cell leukemia and variant hairy cell leukemia]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 38049324 | PubTator, text mining | PubMed |
| RNA-sequencing based first choice of treatment and determination of risk in multiple myeloma. | Front Immunol | 2023 | 38035078 | PubTator, text mining | PubMed |
| Diffuse large B-cell lymphoma with continuously elevated immunoglobulin M following treatment: a case report with pathologic, immunophenotypic, and molecular analyses. | Front Genet | 2023 | 38028606 | PubTator, text mining | PubMed |
| CAR-T Cell Therapy in Large B Cell Lymphoma. | Mediterr J Hematol Infect Dis | 2023 | 38028399 | PubTator, text mining | PubMed |
| Mass spectrometry-based autoimmune profiling reveals predictive autoantigens in idiopathic pulmonary fibrosis. | iScience | 2023 | 38026226 | PubTator, text mining | PubMed |
| Mature B-cell lymphomas in adolescents and young adults. | EJHaem | 2023 | 38024628 | PubTator, text mining | PubMed |
| The implication of next-generation sequencing in the diagnosis and clinical management of non-Hodgkin lymphomas. | Front Oncol | 2023 | 38023160 | PubTator, text mining | PubMed |
| Human CD79b+ neutrophils in the blood are associated with early-stage melanoma. | Front Immunol | 2023 | 38022639 | PubTator, text mining | PubMed |
| Construction of the metabolism-related models for predicting prognosis and infiltrating immune phenotype in lung squamous cell carcinoma. | J Cancer | 2023 | 38021151 | PubTator, text mining | PubMed |
| European survey on neurosurgical management of primary central nervous system lymphomas and preoperative corticosteroid therapy. | Brain Spine | 2023 | 38020980 | PubTator, text mining | PubMed |
| Exploring cyclin-dependent kinase inhibitors: a comprehensive study in search of CDK-6 inhibitors using a pharmacophore modelling and dynamics approach. | RSC Adv | 2023 | 38019988 | PubTator, text mining | PubMed |
| Case of new-onset scleromyxoedema-scleroedema spectrum disorder in a patient with CLL. | RMD Open | 2023 | 38016711 | PubTator, text mining | PubMed |
| Necrotic Ulcers from Occlusive Vasculopathy Associated with Monoclonal B Cell Lymphocytosis. | Acta Derm Venereol | 2023 | 38014831 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/974/papers?page=19